The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In-vitro Diagnostic Services Market Research Report 2024
Synopsis
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations.
Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
The global In-vitro Diagnostic Services market was valued at US$ 64460 million in 2023 and is anticipated to reach US$ 87000 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In-vitro Diagnostic Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Diagnostic Services.
Report Scope
The In-vitro Diagnostic Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-vitro Diagnostic Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-vitro Diagnostic Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioRad
DexCom
Nova Biomedical
OraSure
Pearl Pathways
Phenomenex
Qiagen
Roche Diagnostics
Siemens
Sysmex
Thermofisher
Segment by Type
Infectious Testing
Diabetes Testing
Molecular Testing
Tissue Testing
Segment by Application
Hospitals
Point-Of-Care Testing
Laboratories
Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-vitro Diagnostic Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations.
Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
The global In-vitro Diagnostic Services market was valued at US$ 64460 million in 2023 and is anticipated to reach US$ 87000 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In-vitro Diagnostic Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Diagnostic Services.
Report Scope
The In-vitro Diagnostic Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-vitro Diagnostic Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-vitro Diagnostic Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioRad
DexCom
Nova Biomedical
OraSure
Pearl Pathways
Phenomenex
Qiagen
Roche Diagnostics
Siemens
Sysmex
Thermofisher
Segment by Type
Infectious Testing
Diabetes Testing
Molecular Testing
Tissue Testing
Segment by Application
Hospitals
Point-Of-Care Testing
Laboratories
Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-vitro Diagnostic Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Diagnostic Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infectious Testing
1.2.3 Diabetes Testing
1.2.4 Molecular Testing
1.2.5 Tissue Testing
1.3 Market by Application
1.3.1 Global In-vitro Diagnostic Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Point-Of-Care Testing
1.3.4 Laboratories
1.3.5 Academic Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Diagnostic Services Market Perspective (2019-2030)
2.2 In-vitro Diagnostic Services Growth Trends by Region
2.2.1 Global In-vitro Diagnostic Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In-vitro Diagnostic Services Historic Market Size by Region (2019-2024)
2.2.3 In-vitro Diagnostic Services Forecasted Market Size by Region (2025-2030)
2.3 In-vitro Diagnostic Services Market Dynamics
2.3.1 In-vitro Diagnostic Services Industry Trends
2.3.2 In-vitro Diagnostic Services Market Drivers
2.3.3 In-vitro Diagnostic Services Market Challenges
2.3.4 In-vitro Diagnostic Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Diagnostic Services Players by Revenue
3.1.1 Global Top In-vitro Diagnostic Services Players by Revenue (2019-2024)
3.1.2 Global In-vitro Diagnostic Services Revenue Market Share by Players (2019-2024)
3.2 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-vitro Diagnostic Services Revenue
3.4 Global In-vitro Diagnostic Services Market Concentration Ratio
3.4.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2023
3.5 In-vitro Diagnostic Services Key Players Head office and Area Served
3.6 Key Players In-vitro Diagnostic Services Product Solution and Service
3.7 Date of Enter into In-vitro Diagnostic Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Diagnostic Services Breakdown Data by Type
4.1 Global In-vitro Diagnostic Services Historic Market Size by Type (2019-2024)
4.2 Global In-vitro Diagnostic Services Forecasted Market Size by Type (2025-2030)
5 In-vitro Diagnostic Services Breakdown Data by Application
5.1 Global In-vitro Diagnostic Services Historic Market Size by Application (2019-2024)
5.2 Global In-vitro Diagnostic Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In-vitro Diagnostic Services Market Size (2019-2030)
6.2 North America In-vitro Diagnostic Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In-vitro Diagnostic Services Market Size by Country (2019-2024)
6.4 North America In-vitro Diagnostic Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-vitro Diagnostic Services Market Size (2019-2030)
7.2 Europe In-vitro Diagnostic Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In-vitro Diagnostic Services Market Size by Country (2019-2024)
7.4 Europe In-vitro Diagnostic Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Diagnostic Services Market Size (2019-2030)
8.2 Asia-Pacific In-vitro Diagnostic Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2019-2024)
8.4 Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-vitro Diagnostic Services Market Size (2019-2030)
9.2 Latin America In-vitro Diagnostic Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In-vitro Diagnostic Services Market Size by Country (2019-2024)
9.4 Latin America In-vitro Diagnostic Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Diagnostic Services Market Size (2019-2030)
10.2 Middle East & Africa In-vitro Diagnostic Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2019-2024)
10.4 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioRad
11.1.1 BioRad Company Detail
11.1.2 BioRad Business Overview
11.1.3 BioRad In-vitro Diagnostic Services Introduction
11.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.1.5 BioRad Recent Development
11.2 DexCom
11.2.1 DexCom Company Detail
11.2.2 DexCom Business Overview
11.2.3 DexCom In-vitro Diagnostic Services Introduction
11.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.2.5 DexCom Recent Development
11.3 Nova Biomedical
11.3.1 Nova Biomedical Company Detail
11.3.2 Nova Biomedical Business Overview
11.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
11.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.3.5 Nova Biomedical Recent Development
11.4 OraSure
11.4.1 OraSure Company Detail
11.4.2 OraSure Business Overview
11.4.3 OraSure In-vitro Diagnostic Services Introduction
11.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.4.5 OraSure Recent Development
11.5 Pearl Pathways
11.5.1 Pearl Pathways Company Detail
11.5.2 Pearl Pathways Business Overview
11.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
11.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.5.5 Pearl Pathways Recent Development
11.6 Phenomenex
11.6.1 Phenomenex Company Detail
11.6.2 Phenomenex Business Overview
11.6.3 Phenomenex In-vitro Diagnostic Services Introduction
11.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.6.5 Phenomenex Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen In-vitro Diagnostic Services Introduction
11.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.7.5 Qiagen Recent Development
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Detail
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
11.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.8.5 Roche Diagnostics Recent Development
11.9 Siemens
11.9.1 Siemens Company Detail
11.9.2 Siemens Business Overview
11.9.3 Siemens In-vitro Diagnostic Services Introduction
11.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.9.5 Siemens Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Detail
11.10.2 Sysmex Business Overview
11.10.3 Sysmex In-vitro Diagnostic Services Introduction
11.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.10.5 Sysmex Recent Development
11.11 Thermofisher
11.11.1 Thermofisher Company Detail
11.11.2 Thermofisher Business Overview
11.11.3 Thermofisher In-vitro Diagnostic Services Introduction
11.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2019-2024)
11.11.5 Thermofisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
